Europe: Court awards compensation to Acteon for nullity proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Europe: Court awards compensation to Acteon for nullity proceedings

In a recent ruling by the Court of The Hague (ECLI:NL:RBDHA:2018: 4591) a defendant/patentee has been ordered to pay the costs of nullity proceedings brought against it, despite not wishing to maintain or assert its patent.

Following infringement proceedings instituted in Germany by Dürr Dental based on European patent EP 1 9292 371 B1 against Acteon, the latter company, active in the same field, started nullity proceedings in the Netherlands against the Dutch part of this patent. Instead of providing arguments against the nullity attacks, Dürr Dental said that it had been, and still was, willing to withdraw the Dutch part of the patent. However, due to the pending proceedings, withdrawal of the patent was not possible anymore without the consent of Acteon. Acteon refused to give this. On the basis of this alleged lack of collaboration on the part of Acteon, Dürr Dental argued that Acteon had to bear the costs of the proceedings, brought without a preliminary warning and considered avoidable by Dürr Dental, and that Article 1019h Rv was not applicable in this case.

As a reminder, Article 1019h Rv provides for a reimbursement of costs by the losing party in IP cases. However, case law stipulates that this is not valid for nullity proceedings, except if the nullity proceedings are a defence against an infringement action or can be considered as a prospective defence of non-infringement.

In the absence of a defence, the Court revoked the Dutch part of the patent. With respect to the argument that the proceedings could have been avoided if Acteon had preliminarily warned Dürr Dental, the Court pointed to the fact that Dürr Dental had been paying annuities for several years to maintain the Dutch part of the patent. At the same time, the Court was of the opinion that in light of the infringement proceedings instituted by Dürr Dental in Germany, Acteon had rightfully started the Dutch nullity proceedings as a prospective defence of non-infringement. However, as Dürr Dental had immediately indicated that it did not wish to defend the Dutch part of its European patent, the Court ruled that only the costs incurred by Acteon until the writ was served, were to be borne by Dürr Dental.

Thus, even if a patentee indicates that it does not wish to exercise its patent rights, it can still be ordered to pay the costs of the proceedings.

Eva Eulaers

V.O.

Carnegieplein 5, 2517 KJ

The Hague

The Netherlands

Tel: +31 70 416 67 11

Fax: +31 70 416 67 99

info@vo.eu

www.vo.eu

more from across site and SHARED ros bottom lb

More from across our site

Monetisation is standing at the forefront of patent development, and one firm says AI is increasingly being deployed
Data centres are being built across the US, prompting patent disputes, but Texas’s thriving tech industry and patent-ready courts make the state particularly ‘ripe’ for litigation
Carpmaels & Ransford is set to bolster its UK attorney team with the appointment of Simmons & Simmons’s head of IP in the UK
Updates on Nokia’s licensing strides and a surge in patent activity around battery recycling in Australia were also among the top talking points
To mark International Day Against Child Labour, Matteo Amerio at Corsearch says the people inside businesses who can identify counterfeiting risks must be given the tools and authority to act
With genuine equity at IP firms becoming rarer, securing partnership is harder than ever, but increased transparency is also making climbing the ladder more predictable
Yossi Sivan explains how Israeli judgment is a pro-brand owner departure from the norm and why it sends a strong message that corporate structures are not always a shield
Halim Shehadeh, group CEO of IP firm CWB, says that in the rush to discuss what AI can do, IP firms are overlooking the more important question of whether they are ready
Caitlin Heard, who formally joined the firm from CMS last month, says she is excited by the ‘energy’ of the London office
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Gift this article